LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
20.68 27.76 13 1119 0.0116 -0.1326
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
20.68 27.76 1748 1119 1.5621 1.1745
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
20.68 27.76 1458 1119 1.3029 1.1017
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
20.68 27.76 1583 1119 1.4147 1.1344
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
22.39 27.76 19 1305 0.0146 -0.0660
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
22.39 27.76 1916 1305 1.4674 1.1429
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
22.39 27.76 1638 1305 1.2545 1.0833
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
22.39 27.76 1724 1305 1.3204 1.1026
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
24.09 27.76 29 1461 0.0198 0.0077
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
24.09 27.76 2001 1461 1.3690 1.1129
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
24.09 27.76 1710 1461 1.1699 1.0556
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
24.09 27.76 1774 1461 1.2137 1.0689
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
25.79 27.76 39 1605 0.0243 0.0598
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
25.79 27.76 2185 1605 1.3612 1.1082
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
25.79 27.76 1897 1605 1.1818 1.0579
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
25.79 27.76 1963 1605 1.2229 1.0700
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
27.49 27.76 34 1723 0.0197 0.0346
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
27.49 27.76 2303 1723 1.3365 1.0998
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
27.49 27.76 1963 1723 1.1392 1.0442
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
27.49 27.76 2014 1723 1.1688 1.0531
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
29.19 27.76 53 1863 0.0284 0.1125
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
29.19 27.76 2461 1863 1.3209 1.0939
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
29.19 27.76 2205 1863 1.1835 1.0563
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
29.19 27.76 2254 1863 1.2098 1.0638
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
30.90 27.76 67 2032 0.0330 0.1529
MN20160318_Q01
I12